Lineage Cell Therapeutics: A Viable Speculative Buy for Regenerative Medicine

Lineage Cell Therapeutics (LCTX) is a regenerative medicine company that uses pluripotent stem cells to generate specialized, off-the-shelf human cells to replace damaged tissue in organs. Its OpRegen product aims to regenerate the eyes, spinal cord, auditory, and retinal tissue. Despite the company's financial struggles, it has significant potential for growth and is a viable speculative buy.